In this conversation, we're going to discuss an issue we're seeing bubble rapidly in Germany. However, this issue is rapidly becoming more common globally.
Across Germany, many hospitals are under growing pressure to reduce the cost of high-level disinfection workflows. This is an issue that is cross-departmental. From procurement teams being asked to lower operational spending to clinical teams being asked to do more with fewer staff to hygiene departments facing increasing scrutiny around consistency, validation, and traceability.
The growing trend is to tackle to the above issues one at a time, not comprehensively. Ironically, this has made teams invest more time and resources for lateral moves, like cheaper wipes, then to focus on the root of the problem.
At first glance, this makes sense because chemical wipes are expensive and prices of goods in the global market are continuing to rise, so finding budget reprieve is vital. The problem isn't just the cost of the physical products that teams are buying, rather there's a much larger operational question:
Are hospitals actually modernizing reprocessing workflows, or simply changing suppliers inside the same manual process?
The Hidden Reality Behind “Lower-Cost” Wipes
For many hospitals, the visible cost of high-level disinfection is the chemistry itself, but wipes are only one layer of the total workflow burden.
The larger operational costs are often hidden inside the process:
- manual handling
- staff time
- repeated training
- documentation
- storage
- transport
- contact-time dependency
- audit preparation
- process variability
- device downtime
- probe repairs and replacement
When hospitals switch from one wipe provider to another, many of those operational burdens remain exactly the same. That matters because Germany’s current HLD pressure is no longer only about cost; it is increasingly about consistency.
Germany’s HLD Environment Is Becoming More Complex
German hospitals are operating inside one of the most demanding hygiene environments in Europe. Guidance from organizations such as KRINKO and the Robert Koch Institute continues to raise expectations around validated reprocessing, reproducibility, and infection prevention accountability.
At the same time, hospitals across Germany often experience regional interpretation differences between facilities, hygiene departments, and local implementation expectations.
The result is a growing operational tension because workflows must become more standardized and documentation must become more reliable, but staffing pressure and cost pressure continue to rise simultaneously. That creates a difficult reality for manual wipe-based HLD because even the best wipe protocol still depends heavily on human consistency.
Germany Is Not Alone
What is happening in Germany is not isolated.
Across Europe and internationally, healthcare systems are increasingly moving toward:
- validated workflows
- standardized reprocessing
- traceability
- reproducibility
- reduced dependency on manual variability
In Netherlands, the publication of NEN 8281 created the first formal standard specifically addressing UV-C disinfection for non-critical and semi-critical medical devices, signaling growing recognition of automated UV-C workflows within healthcare disinfection standards.
In Switzerland, reprocessing guidance has continued emphasizing validation, monitoring, and process control for medical device reprocessing.
In the United Kingdom, guidance discussions around ENT endoscope reprocessing have increasingly included UV-C technologies as validated workflow options.
Even outside Europe, high-level disinfection guidance continues evolving toward greater process validation, accountability, and reproducibility rather than reliance on purely manual workflows. The global direction is becoming clearer that healthcare systems need to reduce dependency on inconsistent manual processes wherever possible.
The Bigger Problem With Lateral Moves
This is why hospitals eventually discover that switching wipe suppliers is only a temporary optimization. It doesn't fundamentally reduce the operational complexity surrounding manual HLD and the budgetary benefits aren't guaranteed year-over-year.
Let's remove the other issues of chemical exposure, potential probe damage, staff pressure, etc. Is it worth renegotiating a contract every year that is undoubtedly going to rise? The fixed cost of investing in a product like a D60 creates consistency in tangible and intangbile costs. Reducing the operational burden of manual high-level disinfection is a domino that has a positive ripple effect on your entire organization.
Why UV-C Automation Is Entering the Conversation
This is where automated UV-C systems are beginning to attract more attention across Europe. The conversation is no longer only about sustainability or innovation. It is increasingly about operational efficiency and long-term cost control.
The UV Smart D60 delivers high-level disinfection for channel-less endoscopes and TEE probes in 60 seconds in the EU market. Unlike wipe-based systems, the D60 does not require consumable disinfectants during the disinfection cycle. That changes the financial discussion entirely.
Instead of optimizing consumable purchasing, hospitals can begin reducing:
- recurring chemical costs
- workflow variability
- transportation dependency
- manual documentation burden
- staff workload
- inventory pressure
- environmental waste streams
The system also supports decentralized disinfection workflows, helping reduce transportation needs by up to 2,772 km annually while lowering repair risks and downtime associated with device movement. More importantly, automation reduces dependency on repeated manual execution under pressure.
The Real Question Hospitals Must Ask
The future of HLD is not about which wipe supplier wins market share. The more important question is whether hospitals want to continue investing in workflows that remain heavily dependent on:
- manual repetition
- recurring consumables
- operator variability
- fragmented documentation
- chemical handling
- transport complexity
Because while lateral moves may temporarily lower procurement costs, they often leave the larger operational burden untouched.
Globally, healthcare systems are seeing the scientific data that shows there are options that create workflows that are faster, more standardized, more traceable, and less dependent on manual consistency.
Request a customized Business Case
Facts are important to UV Smart's entire organization. That's why we invite you to request a customized business case. We will evaluate your specific facility's process, input the information into our ROI calculator, and share the outcome. No wide-range guessing, just facts based on your facility.
.jpg)
